Researchers at our partner organisation SCK CEN have recently achieved a new milestone in the development of ISOL@MYRRHA: the first production and mass separation of an ion beam. The team successfully separated the stable isotopes of rubidium using a newly developed ISOL system installed for off-line operation at SCK CEN. More information you can find on the SCK CEN website. 

A PRISMAP session will take place at the Workshop on radionuclide production and medical application (Oslo, 12-16 May 2025), organised by the new Norwegian Nuclear Research Centre at University of Oslo and including a discussion on the preparation of the PRISMAP+ successor project and a Scandinavian node.

You are all very welcome to join and submit an abstract, preferentially by 1 Mar 2025. 

Some grants may be made available to young researchers for travel costs.

Stay tuned, more information and registration will be made available soon. 

You are all cordially invited to the public event, which is being organised in parallel with the upcoming PRISMAP school "Current and Innovative Radionuclides for Medical Imaging and Therapy" in Riga. 

The event aims to highlight advancements in the multidisciplinary field of nuclear medicine, including radiopharmaceutical sciences, radioisotope production, clinical applications, and technological solutions.It is designed for medical doctors, residents, trainees, young researchers, and students at the Bachelor, Master, or PhD level in nuclear medicine, physics, or chemistry, as well as anyone with an interest in the field.

For more details regarding the programme and registration, please refer to the dedicated page on the PRISMAP website. 

The ISOLPHARM group of PRISMAP partner INFN will arrange a thematic workshop entitled 'ISOL technique for the production of medical radionuclides' at the FisMat 2025 conference, which will take place in Venice on 7-11 Jul 2025.

For registration and abstract submission please refer to the workshop webpage. More information about FisMat 2025 you can find on the conference website. 

Submission deadline is 31 Mar 2025. 

Join us for our next PRISMAP school on "Current and Innovative Radionuclides for Medical Imaging and Therapy", taking place on 19-21 Feb 2025 in Riga, Latvia!

The school brings together medical doctors, radiology and nuclear medicine trainees, young researchers and Master and PhD students in nuclear medicine, physics and chemistry from Baltics and Europe with the aim to introduce the latest trends in radiopharmaceutical sciences, including radiolabelled chemistry, synthesis and dosimetry. The event includes theoretical lectures, scientific sessions and a public event.

The course will also include a visit to the Cyclotron facility in Riga and a social programme. Overall, trainees will acquire scientific knowledge to understand the most important aspects in radiochemistry, nuclear medicine, theranostics especially in precision medicine context.

Green light for IMPACT: The upgrade at the proton accelerator facility at the Paul Scherrer Institute PSI planned for the coming years will be implemented. Funding for this two-part enhancement was assured within the framework of the ERI Dispatch 2025-2028. 

More information is available on the PSI website. 

The National Laboratories of Legnaro, part of the Italian National Institute for Nuclear Physics (LNL-INFN) informed today that its SPES facility produced its first radioactive ion beam on 14 Nov 2024. More information is available on their website. 

Institut Laue-Langevin (Grenoble) is hiring a radioisotope production coordinator (indefinite-term-contract). 

The coordinator will liaise with the international radiochemical laboratories that are irradiating samples at the ILL and coordinate work by teams from various ILL services.
Experience in the production of radioisotopes or work in nuclear facilities is an advantage.

More info here.

We are pleased to inform you that for the recent PRISMAP Call 5, we received 22 eligible proposals, 14 of which have now been selected for funding. Further information on the user projects will be published once the PRISMAP user agreements have been signed. Stay tuned!

Congratulations to Mathijs Sevenois (VUB) for receiving the medical applications prize yesterday at the Belgian Nuclear Society (BNS) Young Generation Nuclear Science Contest, for his work titledOptimised solid-phase extraction of 211At: activity balance of 211At, 210At, and 210Po after wet chemistry target dissolution, which was performed in part through his PRISMAP project with partner ARRONAX.

The PRISMAP call 5 will close soon! You can still submit your proposals on the application platform until the deadline of 15 Oct 2024 (end of the day).

We invite you all to propose your projects and to contact us via the helpdesk to discuss them. 

We are looking forward to your project ideas!

The PRISMAP's 7th consortium meeting started today in Nantes. A packed agenda including a one day and a half of consortium meeting and a full day public event hosted by partner ARRONAX at the CHU Nantes.

For the PRISMAP call 5 the application platform is now open and proposals can be submitted anytime until the deadline of 15 Oct 2024.

We invite you all to propose your projects and to contact us via the helpdesk to discuss them. We are looking forward to your project ideas!

The full programme for PRISMAP's webinar for International Day of Women in Radiopharmaceutical Sciences is now available on its dedicated webpage! 

We look forward to seeing you online the 19 August 2024, at 14.00 CEST!

The PRISMAP call 5 for user projects is now open and we invite you all to start preparing your proposals! 

The application procedure,guide for applicants as well as the radionuclide and service portfolio remain unchanged. 

Deadline for submission to this call is 15 Oct 2024 and the online submission portal will be opened end of August. 

Hearings for proposals passing the evaluation threshold will take place on 19 Nov 2024. We strive to complete the evaluation process by 15 Dec 2024 so that the selected projects can start in early 2025. All projects need to be completed by 30 Sep 2025. 

Priorities for selection shall be given to SME candidates, or proof-of-concept experiments with 1 or 2 deliveries, in preparation of an initial clinical pilot phase in humans taking place after PRISMAP. 

In preparation of your proposal, we strongly recommend that all applicants get in contact with us via our helpdesk to discuss their user project idea. In fact, most successful PRISMAP user projects have gone this route, and we will be happy to provide you with a personal PRISMAP mentor for your project application. 

We are looking forward to your proposal ideas!